|
SCFD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.95570000089052E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.985750E-04 |
| Normal-vs-Stage2 |
5.815800E-03 |
| Normal-vs-Stage3 |
3.58219998108922E-09 |
| Normal-vs-Stage4 |
1.74298999999767E-05 |
| Stage1-vs-Stage2 |
5.650600E-01 |
| Stage1-vs-Stage3 |
9.975300E-04 |
| Stage1-vs-Stage4 |
3.540300E-02 |
| Stage2-vs-Stage3 |
1.008020E-01 |
| Stage2-vs-Stage4 |
2.654600E-01 |
| Stage3-vs-Stage4 |
7.161000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.50109999985659E-07 |
| Normal-vs-AfricanAmerican |
4.35259999997939E-06 |
| Normal-vs-Asian |
3.831100E-04 |
| Caucasian-vs-AfricanAmerican |
3.471400E-01 |
| Caucasian-vs-Asian |
2.730400E-01 |
| AfricanAmerican-vs-Asian |
3.379600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.18690002270938E-09 |
| Normal-vs-Female |
1.762850E-03 |
| Male-vs-Female |
6.722100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.156470E-04 |
| Normal-vs-Age(41-60Yrs) |
3.6514000000043E-05 |
| Normal-vs-Age(61-80Yrs) |
3.68329999833605E-08 |
| Normal-vs-Age(81-100Yrs) |
2.666100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.973600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.297800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.071200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.729600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.054800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.098000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.170400E-01 |
| Normal-vs-Grade 2 |
2.224200E-03 |
| Normal-vs-Grade 3 |
9.58489954072661E-10 |
| Normal-vs-Grade 4 |
1.33680000402592E-08 |
| Grade 1-vs-Grade 2 |
1.295580E-02 |
| Grade 1-vs-Grade 3 |
1.324100E-03 |
| Grade 1-vs-Grade 4 |
3.6448999999994E-05 |
| Grade 2-vs-Grade 3 |
9.020400E-04 |
| Grade 2-vs-Grade 4 |
1.648890E-04 |
| Grade 3-vs-Grade 4 |
1.126360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.112200E-02 |
| Normal-vs-ccB subtype |
1.08220099548362E-11 |
| ccA subtype-vs-ccB subtype |
1.40720000096906E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.88289999999425E-05 |
| Normal-vs-N1 |
2.90919999201833E-09 |
| N0-vs-N1 |
1.626230E-04 |
|
|
